„First Line“

Suchergebnisse

3.416 Treffer

• Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer
  Lee, Arnold
• Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
  Laurentiis, Michelino De ; Borstnar, Simona ; Campone, Mario ; Warner, Ellen ; Bofill, Javier Salvador ; Jacot, William ; Dent, Susan ; Martin, Miguel ; Ring, Alistair ; Cottu, Paul ; Lu, Janice ; Ciruelos, Eva ; Azim, Hamdy A. ; Chatterjee, Sanjoy ; Zhou, Katie ; Wu, Jiwen ; Menon-Singh, Lakshmi ; Zamagni, Claudio
• Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study
  Koh, Su-Jin ; Ohsumi, Shozo ; Takahashi, Masato ; Fukuma, Eisuke ; Jung, Kyung Hae ; Ishida, Takanori ; Dai, Ming-Shen ; Chang, Chuan-Hsun ; Dalvi, Tapashi ; Walker, Graham ; Bennett, James ; O’Shaughnessy, Joyce ; Balmaña, Judith
• Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
  Aogi, Kenjiro ; Watanabe, Kenichi ; Kitada, Masahiro ; Sangai, Takafumi ; Ohtani, Shoichiro ; Aruga, Tomoyuki ; Kawagichi, Hidetoshi ; Fujisawa, Tomomi ; Maeda, Shigeto ; Morimoto, Takashi ; Sato, Nobuaki ; Takao, Shintaro ; Morita, Satoshi ; Masuda, Norikazu ; Toi, Masakazu ; Ohno, Shinji
• Erratum zu: Immuntherapie und Tyrosinkinaseinhibitoren beim metastasierten Nierenzellkarzinom in der First-line-Therapie – Wann welche Strategie?
  Mickisch, G. ; Peters, I. ; Grüllich, C. ; Mudra, T. ; Doehn, C.
• Erratum to: The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
  Lerario, Antonio M. ; Worden, Francis P. ; Ramm, Carole A. ; Hesseltine, Elizabeth A. ; Stadler, Walter M. ; Else, Tobias ; Shah, Manisha H. ; Agamah, Edem ; Rao, Krishna ; Hammer, Gary D.
• Correction to: Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer
  Saxena, Puneet ; Singh, Pawan Kumar ; Malik, Prabhat Singh ; Singh, Navneet
• Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
  Yamashita, Toshinari ; Masuda, Norikazu ; Saji, Shigehira ; Araki, Kazuhiro ; Ito, Yoshinori ; Takano, Toshimi ; Takahashi, Masato ; Tsurutani, Junji ; Koizumi, Kei ; Kitada, Masahiro ; Kojima, Yasuyuki ; Sagara, Yasuaki ; Tada, Hiroshi ; Iwasa, Tsutomu ; Kadoya, Takayuki ; Iwatani, Tsuguo ; Hasegawa, Hiroki ; Morita, Satoshi ; Ohno, Shinji
• Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores
  Lee, Hyewon ; Kim, Yu Ri ; Kim, Soo-Jeong ; Park, Yong ; Eom, Hyeon-Seok ; Oh, Sung Yong ; Kim, Hyo Jung ; Kang, Hye Jin ; Lee, Won-Sik ; Moon, Joon Ho ; Won, Young-Woong ; Kim, Tae-Sung ; Kim, Jin Seok
• Correction to: Persistence of High In Vivo Efficacy and Safety of Artesunate–Amodiaquine and Artemether–Lumefantrine as the First- and Second-Line Treatments for Uncomplicated Plasmodium falciparum Malaria 10 Years After Their Implementation in Gabon
  Ndong Ngomo, Jacques M. ; Ondzagha Megnie, Guy J. ; Moutombi Ditombi, Bridy ; Koumba Lengongo, Jeanne V. ; M’Bondoukwé, Noé P. ; Offouga, Christelle L. ; Mawili-Mboumba, Denise P. ; Lekana-Douki, Jean B. ; Ringwald, Pascal ; Fandeur, Thierry ; Bouyou-Akotet, Marielle K.
• Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
  Rivera, Fernando ; Romero, C. ; Jimenez-Fonseca, P. ; Izquierdo-Manuel, M. ; Salud, A. ; Martínez, E. ; Jorge, M. ; Arrazubi, V. ; Méndez, J. C. ; García-Alfonso, P. ; Reboredo, M. ; Barriuso, J. ; Muñoz-Unceta, N. ; Jimeno, R. ; López, C.
• Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
  Ruggeri, Matteo ; Bellasi, Antonio ; Cipriani, Filippo ; Molony, Donald ; Bell, Cynthia ; Russo, Domenico ; Iorio, Biagio Di
• Erratum to: Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary
  Provencio, M. ; Sánchez, A. ; Artal, A. ; Sánchez Torres, J. M. ; García Gómez, R. ; Constenla, M. ; Castro, J. de ; Dómine, M. ; Viñolas, N. ; Pérez, F. J.
• First-Order Representations of Linear Systems
  Kuijper, Margreet 1994 Birkhäuser Boston
• Erratum to: Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy
  Shiramizu, B. ; Ananworanich, J. ; Chalermchai, T. ; Siangphoe, U. ; Troelstrup, D. ; Shikuma, C. ; Gruttola, V. De ; Sithinamsuwan, P. ; Praihirunkit, P. ; Rattanamanee, S. ; Valcour, V.
• Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening
  Beauchamp, Kyle A. ; Taber, Katherine A. Johansen ; Grauman, Peter V. ; Spurka, Lindsay ; Lim-Harashima, Jeraldine ; Svenson, Ashley ; Goldberg, James D. ; Muzzey, Dale
• Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial
  Inoue, Kenichi ; Ninomiya, Jun ; Saito, Tsuyoshi ; Okubo, Katsuhiko ; Nakakuma, Takashi ; Yamada, Hirofumi ; Kimizuka, Kei ; Higuchi, Tohru
• Correction to: Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use
  Lyseng-Williamson, Katherine A.
• Correction to: “Correction to: Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use”
  Lyseng-Williamson, Katherine A.
• Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2− advanced breast cancer in Europe
  Oikonomidou, Olga ; Beresford, Mark J. ; Galve-Calvo, Elena ; Woeckel, Achim ; Parikh, Rohan C. ; Hitchens, Abigail ; Chen, Connie ; Doan, Justin ; Li, Benjamin ; Ansquer, Valerie Derrien ; Frugier, Gaelle ; Jimenez, Maria I. ; Davis, Keith L. ; Broughton, Edward I.